Mr. Camilo Villalba reports

BLUEBERRIES MEDICAL ANNOUNCES INTERNATIONALLY RENOWNED MEDICAL & SCIENTIFIC COMMITTEE

Blueberries Medical Corp. has formed a medical and scientific committee to support management in the development of leading-edge formulations as well as its continuing commercial and educational initiatives. The panel will consist of internationally respected experts and researchers in pharmaceutical, chemistry, biology, engineering, biochemistry and medical fields.

Leveraging its unique and collective expertise in the health care industry in South and North America, the Blueberries medical and scientific committee is focused on the development of innovative formulations to treat specific pathologies, as well as safe and effective treatment regimes. The committee will also assure the quality and certifications of the company's medicinal-grade cannabis oil extracts, oversee the development of cannabis-derived products as well as develop medical education programs for physicians prescribing cannabis-based treatment plans to patients in Latin America.

"We very are fortunate to have assembled a world-class team to comprise our medical and scientific committee. Together, their industry-leading expertise and experience will support and accelerate several key pillars of our business including product formation and commercialization as well as physician and patient education," stated Eduardo Molinari, chief marketing officer. "We look forward to collaborating with each member of the team on the many exciting initiatives currently under way including outreach to the medical community to educate professionals on the applications and benefits of medicinal cannabis. Our goal is ultimately to develop innovative and effective treatment solutions through research and product development that have the ability to positively impact patients in Latin America and globally."

Blueberries Medical scientific committee

Eduardo Molinari -- chief marketing officer

With more than 25 years of experience in the pharmaceutical industry, Mr. Molinari is currently the chief marketing officer for Blueberries Medical Corp. Prior to Blueberries Medical, Mr. Molinari worked for the Abbott Discover team as cell molecular biologist (1995), business unit manager for Argentina (1999), global business development manager for Abbott International (2002), director for Abbott Venezuela (2004) and country manager for Abbott Uruguay (2007). In 2012 when Abbott spun out its pharmaceutical business to form AbbVie, Mr. Molinari was named director for the South American region and general manager in Argentina, and in 2014 he was relocated to Bogota, Colombia, as vice-president of the Northern Latin American region for AbbVie. Before joining Abbott, he was a research technician for Northwestern University in Chicago, Ill., and department chief of pharmacology for Laboratories Beta in Buenos Aires, Argentina. Mr. Molinari earned a master's in business administration from Charles Kellstadt Graduate School of Business at DePaul University of Chicago, and a biochemist degree from the University of Buenos Aires.

Cristina Lucia Mora Arango QF -- director of research and product development

Mrs. Mora Arango is a professional in pharmaceutical chemistry, with a master's in pharmaceutical sciences from the University of Antioquia. Mrs. Mora Arango has more than 10 years of experience and training in research and development in the pharmaceutical, phytotherapeutic, cosmetic and food industries with a specialty in natural products. She has extensive knowledge on the cannabis production process for medicinal use, development of formulations, management of research projects and implementation of the enforced regulatory framework in Colombia for this industry.

Dr. Sandra Paola Santander, PhD

Dr. Santander is a bacteriologist with a PhD in biological sciences from the Pontificia Universidad Javeriana in Bogota, Colombia. Mrs. Santander is an associate researcher at Colciencias, with extensive expertise in the development of new medicines of plant origin (phytomedicines). She is also a researcher in medicinal cannabis and is currently developing a study of the immunomodulatory activity of medicinal cannabis in polarized macrophages.

Fabian Salazar, ChE -- technical director

Mr. Salazar graduated with a degree in chemical engineering from Universidad Nacional de Colombia. Mr. Salazar is the technical director of Blueberries Medical Corp. As an engineer, he has many years of experience in the implementation of processes for vegetal extraction. Mr. Salazar is also an expert in the current cannabis regulation in Colombia.

Dr. Andres Leonardo Vidal Huertas, MD, MG -- medical adviser

Dr. Huertas is a medical adviser for Blueberries Medical. He is also director of El Manantial Medical Center in Bogota, a partner of Blueberries Medical which will provide the platform, resources, patients and expertise needed to commercialize the formulations and products developed through the collaboration with The International Research Center on Cannabis and Mental Health. Dr. Vidal Huertas has a magister degree in pharmacology and nutrition with a specialization in plant pharmacology. He has 14 years of experience in the pharmaceutical industry working in medical management, product management, training management and all the medical language training to easily reach prescribers and patients. Furthermore, Dr. Vidal Huertas has been a university professor for more than 15 years in postgraduate courses for doctors. His experience in pharmacology, plant pharmacology and marketing have been the differential in his career.

This renowned panel will receive insights and support from the following experts and members of The International Research Center on Cannabis and Mental Health (IRCCMH), a leading organization in New York with extensive experience in cannabis research and education, pharmacology, product formulation and the efficacy of cannabis-based treatments.

Dr. Jahan Marcu, PhD

Dr. Marcu is co-founder and former chairman of the cannabis chemistry subdivision (CANN) of the Chemical Health and Safety Division (DCHAS) of the American Chemical Society. He is also on the board of directors of the International Association for Cannabinoids as Medicine. Dr. Marcu has a background in analytical chemistry and molecular pharmacology. He received his PhD for his contributions to characterizing the structure and function of the cannabinoid receptors. He is an author of the American Herbal Pharmacopeia's cannabis monograph and serves on multiple expert government and trade association committees, scientific organizations, and is a court-qualified synthetic cannabinoid and cannabis expert. Dr. Marcu helped create medical cannabis educational training for clinicians and workers in the medical cannabis industry. He has been invited to speak at many international conferences and universities, including the University of Leiden, Temple University School of Medicine, Princeton Hospital and Yale University. Dr. Marcu is also a court qualified expert witness on cannabis and synthetic cannabinoids. He is a recipient of the Billy Martin research award from the International Cannabinoid Research Society.

Dr. Jan Roberts

Dr. Roberts is a clinician and an entrepreneur with extensive experience running both non-profit and for-profit health care organizations. Dr. Roberts teaches at NYU Silver School of Social Work and is currently working on a financed study of mental health clinicians and knowledge and attitudes on cannabis. She is also guest editor for a special issue on cannabis and mental health for the Clinical Social Work Journal (CSWJ). In addition to providing care to patients at her practices in Manhattan and Delaware, Dr. Roberts is one of the founders of the first integrative care centre in Delaware. Her current interest is on the clinical application of cannabis in mental health settings and focusing on maladaptive coping strategies rather than a substance-based approach to treating addictions. She is especially focused on educating fellow mental health clinicians on the most recent research findings to address stigma and lack of knowledge related to cannabis, the endocannabinoid system and mental health outcomes.

About Blueberries Medical Corp.

Blueberries Medical is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries is fully licensed for the cultivation, production, domestic distribution and international export of cannabidiol and tetrahydrocannabinol-based medical cannabis in Colombia. Blueberries' combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the company to become a leading international supplier of naturally grown, processed and standardized medicinal-grade cannabis oil extracts and related products.

We seek Safe Harbor.